Nova Mentis begins recruitment in first-of-its-kind Health Canada psilocybin trial CanadiansInvest
), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders announced that it has begun recruiting participants into the first-ever clinical trial investigating the effects of psilocybin on the cognitive and behavioral symptoms associated with fragile X syndrome , the leading genetic cause of autism spectrum disorder .
“After achieving very positive results in NOVA’s preclinical research, we are eager to begin testing our microdose psilocybin formulation on adult patients diagnosed with fragile X syndrome. Autism is the fastest growing developmental disability in the world and we believe psilocybin therapy has the potential to provide new treatment options for the symptoms associated with this unmet medical need,” stated Dr. Marvin S. Hausman MD, Chairman of NOVA’s Scientific Advisory Board.
NOVA has completed production of pharmaceutical grade cGMP synthetic psilocybin 1.5 mg microdose capsules that will be used in the study. Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova is the first biotech company to achieve orphan drug designation in both the United States and European Union for the use of psilocybin in the treatment of fragile X syndrome .
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Government of Canada restores Hockey Canada fundingThe organization had its funding pulled following the governing body’s handling of a sexual assault case involving members of the...
Read more »
Red Fish Healing Centre posts encouraging early results in Health Canada studyHealth Canada study examined patients before and after treatment stays at Red Fish.
Read more »
BabyTeddy 7-in-1 Convertible Baby Crib poses injury, poisoning risk: Health CanadaHealth Canada is warning consumers to stop using the BabyTeddy 7-in-1 Convertible Baby Crib Wooden Baby Cot because of injury and poisoning risks.
Read more »
GSK plans to buy Canada-based drug developer Bellus Health for $2-billionThe planned purchase comes as GSK expands its bet on respiratory therapies
Read more »
U.S. crackdown on fentanyl trade underway as Canada vows 'public health approach'Senior members of President Joe Biden's cabinet will be in Ottawa in the coming weeks to meet with their Canadian counterparts about cracking down on fentanyl.
Read more »
U.S. crackdown on fentanyl trade underway, Canada vows 'public health approach'WASHINGTON — Senior members of President Joe Biden’s cabinet will be in Ottawa in the coming weeks to meet with their Canadian counterparts about cracking down…
Read more »